Just launched · October 2026—Rankings get sharper with every edition.Spotted an error?Tell us →
Sign in / Register

Guoke Xinglian

Active#47 worldwide · Alternative proteinsNot open to Backers

Estimated valuation · Alternative proteins · China

Produces human milk proteins such as lactoferrin by precision fermentation with food-grade yeast, for infant formula and nutrition makers in China.

HQChina
Last roundSeries A+ · Feb 2026

Estimated valuation

AI · Alternative proteins ranking (worldwide)
≈ USD 75MUSD 38–150M · Tens of M$
Anchor
Last known equity round: Series A+ · USD 14.6M · Feb 2026

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Uback rankings

How the AI ranks →
RankingTierRankEditionNext update
Alternative proteins · worldwideTop 50#47Edition 0 · Oct 202628 Feb 2027
Rank historyOct 2026 · #47 Alternative proteinsFirst edition: no movements yet.

Funding history

DateRoundAmountTypeInvestors
Feb 2026Series A+USD 14.6MEquityShanghai Zhuiguang Julian, Lenovo Capital

CNY 100M.

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Guoke Xinglian as a PDF. It must answer at least one of these four questions, and stick to them:

AI valuation: $75MUndervalued or overvalued?
Versus competitorsHow does it compare?
Who should acquire itStrategic buyers, and why
Who should it acquireAcquisition targets, and why
Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Comparable companies in alternative proteins

Full alternative proteins ranking →

Last updated: Oct 2026Report an error

Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.